Evicenter
Skyrizi (risankizumab-rzaa), All indications
Manufacturer
AbbVie Inc.
Prescribing information
Skyrizi (opens in a new tab)
Questions
17
Indication pages
Plaque psoriasis
Last updated

All questions

Safety: Skyrizi (risankizumab-rzaa), all indications

8 questions · 2 sources

Warnings

Does Skyrizi increase the risk of infections?

Do patients need a TB test before starting Skyrizi?

Note: The adult administration instructions on the dosing page of the Skyrizi HCP site say to evaluate patients for TB infection before starting Skyrizi; the Prescribing Information and the safety page say to consider evaluation based on clinical judgement.

Can Skyrizi cause liver problems?

Note: The first two passages are section 5.4 of the Prescribing Information, which continues across a page break. The liver test schedule in the label applies to Crohn’s disease and ulcerative colitis; the hepatic event rates are from the psoriatic arthritis trials. The safety page of the Skyrizi HCP site lists the warnings and precautions as hypersensitivity, infections, tuberculosis, and immunizations; the current Prescribing Information also lists hepatotoxicity (5.4).

Does Skyrizi have a boxed warning?

Note: The safety page names four warnings and precautions; the current Prescribing Information also lists hepatotoxicity (5.4), described for a patient with Crohn’s disease.

Does Skyrizi have a cancer warning?

Who should not take Skyrizi (contraindications)?

Can Skyrizi cause allergic reactions or anaphylaxis?

Can patients on Skyrizi get vaccines, including live vaccines?